Adverum Biotechnologies Statistics
Total Valuation
ADVM has a market cap or net worth of $190.74 million. The enterprise value is $161.01 million.
| Market Cap | 190.74M |
| Enterprise Value | 161.01M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADVM has 20.75 million shares outstanding. The number of shares has increased by 1.58% in one year.
| Shares Outstanding | 20.75M |
| Shares Change (YoY) | +1.58% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 83.53% |
| Float | 11.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 54.14 |
| Forward PS | n/a |
| PB Ratio | 2.33 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 44.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.77.
| Current Ratio | 4.13 |
| Quick Ratio | n/a |
| Debt / Equity | 0.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -98.60% and return on invested capital (ROIC) is -83.72%.
| Return on Equity (ROE) | -98.60% |
| Return on Assets (ROA) | -52.80% |
| Return on Capital (ROIC) | -83.72% |
| Revenue Per Employee | $29,752 |
| Profits Per Employee | -$968,306 |
| Employee Count | 121 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.63% in the last 52 weeks. The beta is 0.79, so ADVM's price volatility has been lower than the market average.
| Beta (1Y) | 0.79 |
| 52-Week Price Change | +14.63% |
| 50-Day Moving Average | 15.51 |
| 200-Day Moving Average | 13.73 |
| Relative Strength Index (RSI) | 19.99 |
| Average Volume (30 Days) | 301,148 |
Short Selling Information
The latest short interest is 1.13 million, so 5.45% of the outstanding shares have been sold short.
| Short Interest | 1.13M |
| Short Previous Month | 889,950 |
| Short % of Shares Out | 5.45% |
| Short % of Float | 9.65% |
| Short Ratio (days to cover) | 3.81 |
Income Statement
In the last 12 months, ADVM had revenue of $3.60 million and -$117.17 million in losses. Loss per share was -$11.60.
| Revenue | 3.60M |
| Gross Profit | 3.60M |
| Operating Income | -123.99M |
| Pretax Income | -118.24M |
| Net Income | -117.17M |
| EBITDA | -99.57M |
| EBIT | -118.24M |
| Loss Per Share | -$11.60 |
Balance Sheet
The company has $98.50 million in cash and $64.63 million in debt, giving a net cash position of $33.88 million or $1.63 per share.
| Cash & Cash Equivalents | 98.50M |
| Total Debt | 64.63M |
| Net Cash | 33.88M |
| Net Cash Per Share | $1.63 |
| Equity / Book Value | 83.47M |
| Book Value Per Share | 4.02 |
| Working Capital | 77.86M |
Cash Flow
In the last 12 months, operating cash flow was -$90.90 million and capital expenditures -$808,000, giving a free cash flow of -$91.71 million.
| Operating Cash Flow | -90.90M |
| Capital Expenditures | -808,000 |
| Free Cash Flow | -91.71M |
| FCF Per Share | -$9.10 |
Margins
Gross margin is 100.00%, with operating and profit margins of -3,444.19% and -3,254.58%.
| Gross Margin | 100.00% |
| Operating Margin | -3,444.19% |
| Pretax Margin | -3,284.53% |
| Profit Margin | -3,254.58% |
| EBITDA Margin | -2,765.89% |
| EBIT Margin | -3,284.53% |
| FCF Margin | -2,547.50% |
Dividends & Yields
ADVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.58% |
| Shareholder Yield | -1.58% |
| Earnings Yield | -60.12% |
| FCF Yield | -47.06% |
Analyst Forecast
The average price target for ADVM is $40.00, which is 335.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.00 |
| Price Target Difference | 335.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 44.19% |
| EPS Growth Forecast (5Y) | -43.67% |
Stock Splits
The last stock split was on March 21, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Mar 21, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ADVM has an Altman Z-Score of -7.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.83 |
| Piotroski F-Score | 2 |